Jon Cogan

Also affiliated with VasGene Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Over‐expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas”.

Over‐expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas

Experimental Dermatology(2021)10.1111/exd.14281

N/A

0DataRank · unranked

18 citations

Lyu Chao, David T. Woodley, Dédée F. Murrell, Minhee Kim, Edel A. O’Toole +6 more

Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa

Journal of Dermatological Science(2021)10.1016/j.jdermsci.2021.09.006

N/A

0DataRank · unranked

7 citations

Jon Cogan, Daniel Mosallaei, Kaitlyn Yim, Mei Chen, David T. Woodley

Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial

British Journal of Dermatology(2024)10.1093/bjd/ljae063

N/A

0DataRank · unranked

13 citations

Michelle Hao, Andrew Kwong, Brandon Levian, Jon Cogan, Yingping Hou +8 more